NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1427492826 M.D.
Verify on CMS → Kyle Chapman, M.D.
Pulmonary Disease Physician in Morgantown, West Virginia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 111 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
0%
generic claims · 56% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.1/100
▲ 11 pts above national avg 83.5 · Exceptional
Industry payments
$1.5K
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Kyle Chapman, M.D. reported a CMS MIPS final score of 94.1/100 - above the 83.5 national average - and filed 1,107 Medicare Part D claims in 2024.
- 94.1/100
- MIPS score · +11 vs avg
- 1K
- Part D claims, 2024
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Kyle Chapman, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1427492826), first enumerated 04/29/2013.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,107 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 94.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.5K in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1427492826 · Pulmonary Disease Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ELITE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1427492826
- ENUM-MID 2013
- TAX-MID 10K Pulmonary Disease
- MIPS-ELITE 94.1/100
- RX-MID 1,107
- BOOK-THIN 71 in West Virginia
- PHOTO-FINISH Aneeqah Baig · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Chapman · this p…
Chapman · this provider
94.1 MIPS pts
- Vipin Villgran ·…
Vipin Villgran
94.1 MIPS pts
- Aneeqah Baig · n…
Aneeqah Baig
94.1 MIPS pts
- Keith Niggemyer …
Keith Niggemyer
94.1 MIPS pts
- Boyd Sprenkle · …
Boyd Sprenkle
94.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Kyle Chapman, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
94 ≥ 73rd percentile 73% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Kyle Chapman, M.D. sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Kyle Chapman, M.D. writes more Part D claims than 53% of them and scores higher on MIPS quality than 74% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Kyle Chapman, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Kyle Chapman, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kyle Chapman, M.D.?
High performer (top quartile)Primary specialty
Pulmonary Disease Physician
Medicare Part D claims
1,107 26% vs specialty avg
MIPS final score
94.1/100 10.6 pts vs avg
Specialty distribution in West Virginia
How Pulmonary Disease Physician compares to other specialties among West Virginia providers
Medicare quality performance, MIPS
Kyle Chapman, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 94.1/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1427492826 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/29/2013 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
94.1061
Final Score
Measured-score avg: 83.5
78.4655
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Kyle Chapman, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
West Virginia University Medical Corporation
Morgantown, WV
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Kyle Chapman, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.5K
Largest payer
Canon Medical Systems USA, Inc.
Most common payment type
Consulting Fee
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Kyle Chapman, M.D. - brand share 56.0%
Pulmonary Disease Physician average
56% brand-name claims vs 0% generic, on 1,107 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,107
Total Claims
$4.8M
Total Drug Cost
111
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,507.2
- Total Day Supply
- 43,007
- Brand vs Generic
- 56% brand / 0% generic
- Brand Drug Cost
- $4.7M
- Antibiotic Claims
- 73
Patient Demographics
- Average Patient Age
- 65.5 years
- Avg HCC Risk Score
- 2.26
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 36, 65-74: 41, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Kyle Chapman, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Trikafta
Trikafta
129 claims
- Montelukast Sodium
Montelukast Sodium
120 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
72 claims
- Azithromycin
Azithromycin
54 claims
- Fluticasone Propio… 50
Fluticasone Propionate
50 claims
- Budesonide-Formote… 45
Budesonide-Formoterol Fumarate
45 claims
- Creon 43
Creon
43 claims
- Omeprazole 39
Omeprazole
39 claims
| Drug | Claims |
|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 129 |
| Montelukast Sodium | 120 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 72 |
| Azithromycin | 54 |
| Fluticasone Propionate | 50 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 45 |
| Creon Lipase/Protease/Amylase | 43 |
| Omeprazole | 39 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 36 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 30 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Kyle Chapman, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Kyle Chapman, M.D.'s 1,107 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Chapman, both outside West Virginia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (94.1 here).
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in West Virginia
Other clinicians with the same primary specialty enrolled in West Virginia, drawn from the same CMS NPPES roster as Chapman.
One of 71 Pulmonary Disease Physician providers enrolled in West Virginia, 5 are shown here.
Rime Abbas
Morgantown, WV
Dr. Peter Abbrecht
M.D.
Shepherdstown, WV
Amirahwaty Abdullah
Morgantown, WV
Dr. Roger Abrahams
M.D.
Morgantown, WV
Dr. Jamil Ahmed
MD
Fairmont, WV
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Kyle Chapman, M.D.'s specialty? ▼
Kyle Chapman, M.D. specializes in Pulmonary Disease Physician and practices in Morgantown, West Virginia. Credentials: M.D..
How much does Kyle Chapman, M.D. prescribe under Medicare Part D? ▼
In 2024, Kyle Chapman, M.D. wrote 1,107 Medicare Part D claims totaling $4.8M in drug costs for 111 beneficiaries.
What is Kyle Chapman, M.D.'s Medicare quality score? ▼
Kyle Chapman, M.D. has a CMS MIPS Final Score of 94.1/100 (Quality: 78.5). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Kyle Chapman, M.D. located? ▼
Kyle Chapman, M.D. is located at 1 MEDICAL CENTER DR, Morgantown, WV, 26506. Phone: (304) 598-4800.
What is Kyle Chapman, M.D.'s NPI number? ▼
Kyle Chapman, M.D.'s National Provider Identifier (NPI) is 1427492826, issued on 04/29/2013.
Does Kyle Chapman, M.D. prescribe more brand-name or generic drugs? ▼
Kyle Chapman, M.D.'s prescribing is 56% brand-name and 0% generic drugs by claim count, with $4.7M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Kyle Chapman, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Kyle Chapman, M.D.'s most frequently prescribed drugs include Trikafta, Montelukast Sodium, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kyle Chapman, M.D. accept Medicare? ▼
Kyle Chapman, M.D. appears in CMS Medicare data with 1,107 Part D claims and 111 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kyle Chapman, M.D.'s credentials? ▼
Kyle Chapman, M.D.'s NPI is 1427492826 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.